Literature DB >> 3502

Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3H-androgens.

K C Reed, S Ohno.   

Abstract

The rapid and sensitive assay of 1beta,2beta-3H-androgen aromatization by measurement of 3H2O release (Thompson, E.A., Jr., and Siiteri, P.K. (1974) J. Biol. Chem. 249, 5364-5372) has been analyzed to determine its applicability to initial rate studies. It was found that aromatization is the sole reaction catalyzed by lyophilized placental microsomes that causes a loss of tritium from position 1 or 2 of androstenedione and testosterone. Tritium is, however, removed from position 2 of the estrogen products, presumably in 2-hydroxylation, but this does not invalidate use of the assay for initial rate measurements; it was therefore used to characterize the catalytic properties of aromatase. Aromatization by the freeze-dried preparation was stimulated by K+, EDTA, and dithiothreitol, and was maximally active at pH 7.5 TO 8.0. With incubation conditions optimized for these factors, the apparent Km for NADPH is approximately 1 muM. The maximum velocity of androstenedione aromatization exceeds that of testosterone, and the affinity of the substrate binding site is higher for the former substrate, the apparent Km values being 0.1 muM and 0.4 muM, respectively. Mutual competition experiments with the androgen substrates showed that each gives simple competitive inhibition of the other's aromatization; furthermore, the apparent Ki values for each are in close agreement with their respective Km values. Androst-1,4,6-triene-3,17-dione competitively inhibits the aromatization of both androstenedione and testosterone, the apparent Ki, in both cases being 0.2 muM. It is concluded that the two androgen substrates are aromatized at a single, identical site.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Inability of second trimester human amniotic fluid cell cultures to aromatize C19-steroids.

Authors:  D J O'Shannessy; A G Renwick
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

Review 2.  Aromatase, aromatase inhibitors, and breast cancer.

Authors:  Saranya Chumsri; Timothy Howes; Ting Bao; Gauri Sabnis; Angela Brodie
Journal:  J Steroid Biochem Mol Biol       Date:  2011-02-16       Impact factor: 4.292

3.  Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase.

Authors:  P A Cole; J M Bean; C H Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Effects of aromatase inhibition and androgen activity on serotonin and behavior in male macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy; Nicola Robertson; Kristine Coleman
Journal:  Behav Neurosci       Date:  2013-03-18       Impact factor: 1.912

Review 5.  Estrogen signaling in metabolic inflammation.

Authors:  Rosário Monteiro; Diana Teixeira; Conceição Calhau
Journal:  Mediators Inflamm       Date:  2014-10-23       Impact factor: 4.711

6.  Synthesis and screening of aromatase inhibitory activity of substituted C19 steroidal 17-oxime analogs.

Authors:  Muna Pokhrel; Eunsook Ma
Journal:  Molecules       Date:  2011-11-28       Impact factor: 4.411

7.  A Fluorometric CYP19A1 (Aromatase) Activity Assay in Live Cells.

Authors:  David K Heidary; Sarah M Kriger; Austin C Hachey; Edith C Glazer
Journal:  ChemMedChem       Date:  2021-07-05       Impact factor: 3.540

8.  Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells.

Authors:  Michael Gal; Joseph Orly
Journal:  Clin Med Insights Reprod Health       Date:  2014-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.